Braveheart Investment Group plc Update to the Market (4455B)

TIDMBRH

RNS Number : 4455B

Braveheart Investment Group plc

07 June 2019

7 June 2019

Braveheart Investment Group plc

("Braveheart" or the "Company")

Update to the Market

Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, is pleased to announce that the audit of its accounts for the year ended 31 March 2019 is now proceeding. As indicated at the time of the release of the Interim Results for the six months ended 30 September 2018, it is expected that the audit process will take longer to complete this year than in previous years because of the added work and complications that have arisen from having to consolidate into Braveheart's accounts the accounts of Kirkstall Limited and Paraytec Limited, two of Braveheart's Strategic Investments. This consolidation of these two underlying investments is required as a result of Braveheart now owning in excess of 50 per cent. of these companies and exerting significant managerial control over them.

The Board has continued to focus heavily on the existing Strategic Investments, Kirkstall Limited, Paraytec Limited and Gyrometric Systems Limited.

Paraytec has recently spun out to its shareholders, Sentinel Medical Limited, a company which will seek to exploit the technology developed by Paraytec to detect cancer cells in urine. Braveheart now holds a 32.8 per cent. interest in Sentinel Limited and considers this to be a separate Strategic Investment.

In addition, Braveheart recently acquired a 21.2 per cent. interest in PhaseFocus Holdings Limited which owns 100 per cent. of the issued share capital of Phase Focus Limited, a revenue producing company which uses novel computational methods to enhance image quality in both optical and electron microscopes.

As a result of these developments, Braveheart now holds investments in five Strategic Investments alongside its portfolio of other historic investments.

The Board expects to announce its results for the year ended 31 March 2019 in late July 2019 and therefore intends to hold the Annual General Meeting in late August 2019.

For further information:

 
 Braveheart Investment Group plc              Tel: [phone] 
  Trevor Brown, Chief Executive Officer 
 Allenby Capital Limited (Nominated Adviser   Tel: [phone] 
  and Joint Broker) 
  David Worlidge / Nicholas Chambers 
  Peterhouse Capital Limited (Joint Broker)    Tel: [phone] 
   Heena Karani / Lucy Williams 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCFFMFTMBMMBJL

(END) Dow Jones Newswires

June 07, 2019 02:00 ET (06:00 GMT)